Rhophylac Alternatives Compared
Rhophylac | Nplate | Promacta |
|
---|
Rhophylac (rho (d) immune globulin) | Nplate (romiplostim) | Promacta (eltrombopag) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Rh-Isoimmunization, Immune Thrombocytopenia. Rhophylac may also be used for purposes not listed in this medication guide. |
Prescription only
Nplate may be used to increase platelet counts above 50 x 109/L in adults and children with ITP who have not had a good response to corticosteroids, immunoglobulins, or removal of their... View more |
Prescription only
Promacta is an oral tablet or suspension that is taken daily to boost platelet numbers in people with chronic ITP, severe aplastic anemia, or chronic hepatitis C. Nausea, diarrhea, infections, and... View more |
Related suggestions Immune Thrombocytopenia
Popular comparisons
|
|||||||||||||||||||||||
More about Rhophylac (rho (d) immune globulin) | More about Nplate (romiplostim) | More about Promacta (eltrombopag) | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Rhophylac has an average rating of 1.0 out of 10 from a total of 1 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 100% reported a negative effect. |
Nplate has an average rating of 7.6 out of 10 from a total of 9 ratings on Drugs.com. 78% of reviewers reported a positive effect, while 11% reported a negative effect. |
Promacta has an average rating of 7.1 out of 10 from a total of 17 ratings on Drugs.com. 64% of reviewers reported a positive effect, while 21% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: Rhophylac side effects in more detail. |
See also: Nplate side effects in more detail. |
See also: Promacta side effects in more detail. |
||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
N/A |
N/A |
|||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Rhophylac prices |
View all Nplate prices |
View all Promacta prices |
||||||||||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Other rho (d) immune globulin brands include: Anti-D (RHO) Immunoglobulin, BayRHo-D, BayRHo-D Full Dose, BayRHo-D Mini-Dose, D-Gam Anti-D, Gamulin Rh, HyperRHO S/D Full Dose, HyperRHO S/D Mini-Dose, HypRho-D Mini-Dose, MicRhoGAM Ultra-Filtered Plus, RhoGAM Ultra-Filtered Plus, WinRho SDF View more |
N/A |
Other eltrombopag brands include: Alvaiz | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
624 hours |
816 hours |
35 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 101 drugs are known to interact with Rhophylac:
|
A total of 9 drugs are known to interact with Nplate:
|
A total of 177 drugs are known to interact with Promacta:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
N/A |
August 22, 2008 |
November 20, 2008 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.